Pulmonary thoracic disorders encompass a wide range of conditions that affect both the lungs and the thoracic structures surrounding them, including the pleura, chest wall, and diaphragm. These disorders can arise from congenital anomalies, infections, trauma, neoplasms, or chronic systemic diseases, leading to impaired respiratory mechanics, reduced lung expansion, and compromised gas exchange. Common manifestations include dyspnea, chest pain, cough, and in severe cases, respiratory failure. Evaluation of pulmonary thoracic disorders relies on a combination of clinical examination, imaging, and functional testing. Chest radiography and computed tomography provide detailed visualization of lung parenchyma, pleural spaces, and thoracic structures, aiding in identifying abnormalities such as effusions, masses, or deformities. Pulmonary function tests measure lung volumes, compliance, and airflow, offering insights into restrictive or obstructive patterns. In selected cases, minimally invasive procedures such as thoracoscopy or biopsy are employed to obtain tissue samples for definitive diagnosis. Management strategies are tailored to the specific disorder and its severity. Therapeutic approaches may include medical management, such as antibiotics or anti-inflammatory agents, interventional procedures like pleural drainage or thoracic surgery, and supportive care, including oxygen therapy and pulmonary rehabilitation. Advances in imaging, minimally invasive surgery, and targeted pharmacologic treatments have improved both diagnostic accuracy and therapeutic outcomes. By integrating precise evaluation, individualized treatment, and supportive care, the management of pulmonary thoracic disorders aims to restore respiratory function, relieve symptoms, and enhance quality of life for patients with complex thoracic and pulmonary conditions.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation